Analyze Diet
Hepatology (Baltimore, Md.)2015; 61(5); 1533-1546; doi: 10.1002/hep.27689

Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus.

Abstract: Equine hepacivirus (EHCV; nonprimate hepacivirus) is a hepatotropic member of the Flaviviridae family that infects horses. Although EHCV is the closest known relative to hepatitis C virus (HCV), its complete replication kinetics in vivo have not been described, and direct evidence that it causes hepatitis has been lacking. In this study, we detected EHCV in 2 horses that developed post-transfusion hepatitis. Plasma and serum from these horses were used to experimentally transmit EHCV to 4 young adult Arabian horses, two 1-month-old foals (1 Arabian and 1 Arabian-pony cross), and 2 foals (1 Arabian and 1 Arabian-pony cross) with severe combined immunodeficiency (SCID). Our results demonstrated that EHCV had infection kinetics similar to HCV and that infection was associated with acute and chronic liver disease as measured by elevations of liver-specific enzymes and/or by histopathology. Although most of these animals were coinfected with equine pegivirus (EPgV), also a flavivirus, EPgV viral loads were much lower and often undetectable in both liver and blood. Three additional young adult Arabian-pony crosses and 1 SCID foal were then inoculated with plasma containing only EHCV, and evidence of mild hepatocellular damage was observed. The different levels of liver-specific enzyme elevation, hepatic inflammation, and duration of viremia observed during EHCV infection suggested that the magnitude and course of liver disease was mediated by the virus inoculum and/or by host factors, including breed, age, and adaptive immune status. Conclusions: This work documents the complete infection kinetics and liver pathology associated with acute and chronic EHCV infection in horses and further justifies it as a large animal model for HCV.
Publication Date: 2015-02-24 PubMed ID: 25580897DOI: 10.1002/hep.27689Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers of this study explored how equine hepacivirus (EHCV), a virus similar to the hepatitis C virus (HCV) in humans and found in horses, could be transmitted and cause liver disease. The experiment involved infecting different breeds and ages of horses with the EHCV, studying the virus’s infection kinetics (how it spreads and replicates in the body), comparing it to HCV, and observing for signs of liver disease.

Study Design and Methodology

  • The researchers observed two horses that had developed post-transfusion hepatitis and detected EHCV in these animals.
  • They then utilized the plasma and serum from the infected horses to experimentally transmit EHCV to four young adult Arabian horses, two foals of different breeds, and two foals with severe combined immunodeficiency (SCID).
  • Three additional young Arabian-pony crosses and a SCID foal were given plasma containing only EHCV to provide further data and prove that the virus itself caused the liver disease.

Results and Findings

  • The study found that the EHCV infection and replication kinetics were similar to those of HCV.
  • Evidence of acute and chronic liver disease was observed in infected horses through elevated liver-specific enzymes and changes in liver tissues – indicative of pathology.
  • Interestingly, some horses were coinfected with equine pegivirus (EPgV), another virus from the Flaviviridae family, but the negative impact from this coinfection wasn’t as severe.
  • There were variations in liver-specific enzyme elevation, inflammation, and the duration of viremia (presence of viruses in the blood), and these changes were attributed to factors such as virus load, horse breed, age, and immune status.

Conclusion & Implication

  • The study confirmed that EHCV is a cause of liver disease in horses, similar to the role of HCV in humans.
  • The findings provide a new perspective on the EHCV infection process, from kinetics and replication to the resulting liver pathology.
  • This research could also be valuable in studying HCV in humans by using the horse as a large animal model for the virus. The discovered similarities between EHCV and HCV might offer insight into the human version of the virus and help develop treatment strategies.

Cite This Article

APA
Ramsay JD, Evanoff R, Wilkinson TE, Divers TJ, Knowles DP, Mealey RH. (2015). Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus. Hepatology, 61(5), 1533-1546. https://doi.org/10.1002/hep.27689

Publication

ISSN: 1527-3350
NlmUniqueID: 8302946
Country: United States
Language: English
Volume: 61
Issue: 5
Pages: 1533-1546

Researcher Affiliations

Ramsay, Joshua D
  • Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA.
Evanoff, Ryan
    Wilkinson, Tom E
      Divers, Thomas J
        Knowles, Donald P
          Mealey, Robert H

            MeSH Terms

            • Animals
            • Disease Models, Animal
            • Hepatitis C, Chronic / transmission
            • Hepatitis C, Chronic / veterinary
            • Horse Diseases / transmission
            • Horse Diseases / virology
            • Horses

            Citations

            This article has been cited 52 times.
            1. Hake N, von Holtum C, Höper D, Nijhof AM, Dietze K, Hoffmann B. Identification and Long-Term Detection of Hepacivirus bovis Genotype 1 and 2 on a Cattle Farm in Germany. Viruses 2026 Jan 6;18(1).
              doi: 10.3390/v18010078pubmed: 41600842google scholar: lookup
            2. Kayesh MEH, Sanada T, Kohara M, Tsukiyama-Kohara K. Natural Hepacivirus Infection in Tree Shrews: A Call for Routine Screening in Hepatitis Virus Research. Viruses 2025 Dec 23;18(1).
              doi: 10.3390/v18010027pubmed: 41600792google scholar: lookup
            3. Atasoy MO, Turan T, Özbek R, Işıdan H, Naggar RFE, Afify AF, Rohaim MA. Evaluation of Risk Determinants and Molecular Characterisation for Non-Primate Hepacivirus Infection in Turkish Horses. Pathogens 2025 Dec 8;14(12).
              doi: 10.3390/pathogens14121256pubmed: 41471211google scholar: lookup
            4. Jager MC, Luethy D, Shallop S, Cathcart J, Divers TJ, Tan JY, Beasley EM, Johnson P, Leduc L, Smith C, Jamieson CA, Magdesian KG, Van de Walle GR, Tomlinson JE. Chronic hepatitis in horses with persistent equine hepacivirus infection. Equine Vet J 2026 Mar;58(2):444-457.
              doi: 10.1111/evj.70124pubmed: 41448947google scholar: lookup
            5. Pourmahdi Borujeni M, Ghobadian Diali H, Mashhadi AG, Aliabad MJ. First Detection and Phylogenetic Analysis of Equine Hepacivirus (EqHV) in Iran. Vet Med Sci 2026 Jan;12(1):e70737.
              doi: 10.1002/vms3.70737pubmed: 41420497google scholar: lookup
            6. Ricci I, Rosone F, Pacchiarotti G, Manna G, Cersini A, Carvelli A, La Rocca D, Cammalleri E, Giordani R, Tofani S, Conti R, Rombolà P, Nardini R, Minniti CA, Caforio R, Linardi B, Scicluna MT. Pegiviruses and Coronavirus: Biomolecular Prevalence and Phylogenetic Analysis of Strains Detected in Italian Horse Populations. Viruses 2025 Aug 2;17(8).
              doi: 10.3390/v17081076pubmed: 40872790google scholar: lookup
            7. Frisch V, Ramsauer AS, Preining I, Unterköfler MS, Fuehrer HP, Hofer M, Lyrakis M, Bouhsira E, Liénard E, Cavalleri JV. First detection of equine hepacivirus RNA in Stomoxys calcitrans (Diptera, Muscidae) in eastern Austria. BMC Vet Res 2025 Jul 17;21(1):474.
              doi: 10.1186/s12917-025-04890-xpubmed: 40676642google scholar: lookup
            8. Cardone R, Buonavoglia A, Lanave G, Vasinioti VI, Mininni V, Lorusso E, Decaro N, Martella V, Elia G, Diakoudi G. Description of an Equine Hepacivirus Cluster in a Horse Stable in Italy. Transbound Emerg Dis 2023;2023:5251034.
              doi: 10.1155/2023/5251034pubmed: 40303682google scholar: lookup
            9. Nardini R, Pacchiarotti G, Svicher V, Salpini R, Bellocchi MC, Conti R, Sala MG, La Rocca D, Carioti L, Cersini A, Manna G, The Equine Hepatic Viruses Consortium, Scicluna MT. First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus. Viruses 2024 Apr 16;16(4).
              doi: 10.3390/v16040616pubmed: 38675957google scholar: lookup
            10. Jager MC, Choi E, Tomlinson JE, Van de Walle G. Naturally acquired equine parvovirus-hepatitis is associated with a wide range of hepatic lesions in horses. Vet Pathol 2024 May;61(3):442-452.
              doi: 10.1177/03009858231214024pubmed: 38018088google scholar: lookup
            11. Cavalleri JV, Korbacska-Kutasi O, Leblond A, Paillot R, Pusterla N, Steinmann E, Tomlinson J. European College of Equine Internal Medicine consensus statement on equine flaviviridae infections in Europe. J Vet Intern Med 2022 Nov;36(6):1858-1871.
              doi: 10.1111/jvim.16581pubmed: 36367340google scholar: lookup
            12. Pacchiarotti G, Nardini R, Scicluna MT. Equine Hepacivirus: A Systematic Review and a Meta-Analysis of Serological and Biomolecular Prevalence and a Phylogenetic Update. Animals (Basel) 2022 Sep 20;12(19).
              doi: 10.3390/ani12192486pubmed: 36230228google scholar: lookup
            13. Gömer A, Delarocque J, Puff C, Nocke MK, Reinecke B, Baumgärtner W, Cavalleri JMV, Feige K, Steinmann E, Todt D. Dose-Dependent Hepacivirus Infection Reveals Linkage between Infectious Dose and Immune Response. Microbiol Spectr 2022 Oct 26;10(5):e0168622.
              doi: 10.1128/spectrum.01686-22pubmed: 35993785google scholar: lookup
            14. Breitfeld J, Fischer N, Tsachev I, Marutsov P, Baymakova M, Plhal R, Keuling O, Becher P, Baechlein C. Expanded Diversity and Host Range of Bovine Hepacivirus-Genomic and Serological Evidence in Domestic and Wild Ruminant Species. Viruses 2022 Jun 30;14(7).
              doi: 10.3390/v14071457pubmed: 35891438google scholar: lookup
            15. Badenhorst M, Saalmüller A, Daly JM, Ertl R, Stadler M, Puff C, de le Roi M, Baumgärtner W, Engelmann M, Brandner S, Junge HK, Pratscher B, Volz A, Saunier B, Krey T, Wittmann J, Heelemann S, Delarocque J, Wagner B, Todt D, Steinmann E, Cavalleri JV. An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation. Viruses 2022 Jun 27;14(7).
              doi: 10.3390/v14071401pubmed: 35891381google scholar: lookup
            16. Lu G, Chen C, Shao R, Zhang J, Li J, Cai S, Zhong L, Lai Z, Ou J, Yin X, Zhang G, Li S. Identification and genetic characterization of bovine hepacivirus in China: A large scale epidemiological study. Virol Sin 2022 Apr;37(2):223-228.
              doi: 10.1016/j.virs.2022.02.003pubmed: 35537981google scholar: lookup
            17. Gömer A, Puff C, Reinecke B, Bracht S, Conze M, Baumgärtner W, Steinmann J, Feige K, Cavalleri JMV, Steinmann E, Todt D. Experimental cross-species infection of donkeys with equine hepacivirus and analysis of host immune signatures. One Health Outlook 2022 May 9;4(1):9.
              doi: 10.1186/s42522-022-00065-ypubmed: 35527255google scholar: lookup
            18. Satué K, Miguel-Pastor L, Chicharro D, Gardón JC. Hepatic Enzyme Profile in Horses. Animals (Basel) 2022 Mar 29;12(7).
              doi: 10.3390/ani12070861pubmed: 35405850google scholar: lookup
            19. Gömer A, Brown RJP, Pfaender S, Deterding K, Reuter G, Orton R, Seitz S, Bock CT, Cavalleri JMV, Pietschmann T, Wedemeyer H, Steinmann E, Todt D. Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance. Virus Evol 2022;8(1):veac007.
              doi: 10.1093/ve/veac007pubmed: 35242360google scholar: lookup
            20. Röhrs S, Begeman L, Straub BK, Boadella M, Hanke D, Wernike K, Drewes S, Hoffmann B, Keller M, Drexler JF, Drosten C, Höper D, Kuiken T, Ulrich RG, Beer M. The Bank Vole (Clethrionomys glareolus)-Small Animal Model for Hepacivirus Infection. Viruses 2021 Dec 3;13(12).
              doi: 10.3390/v13122421pubmed: 34960690google scholar: lookup
            21. Tomlinson JE, Wolfisberg R, Fahnøe U, Patel RS, Trivedi S, Kumar A, Sharma H, Nielsen L, McDonough SP, Bukh J, Tennant BC, Kapoor A, Rosenberg BR, Rice CM, Divers TJ, Van de Walle GR, Scheel TKH. Pathogenesis, MicroRNA-122 Gene-Regulation, and Protective Immune Responses After Acute Equine Hepacivirus Infection. Hepatology 2021 Sep;74(3):1148-1163.
              doi: 10.1002/hep.31802pubmed: 33713356google scholar: lookup
            22. Patel RS, Tomlinson JE, Divers TJ, Van de Walle GR, Rosenberg BR. Single-cell resolution landscape of equine peripheral blood mononuclear cells reveals diverse cell types including T-bet(+) B cells. BMC Biol 2021 Jan 22;19(1):13.
              doi: 10.1186/s12915-020-00947-5pubmed: 33482825google scholar: lookup
            23. Simmonds P, Cuypers L, Irving WL, McLauchlan J, Cooke GS, Barnes E, Ansari MA. Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus. RNA 2020 Nov;26(11):1541-1556.
              doi: 10.1261/rna.075465.120pubmed: 32747607google scholar: lookup
            24. Berggren KA, Suzuki S, Ploss A. Animal Models Used in Hepatitis C Virus Research. Int J Mol Sci 2020 May 29;21(11).
              doi: 10.3390/ijms21113869pubmed: 32485887google scholar: lookup
            25. Vengust M, Jager MC, Zalig V, Cociancich V, Laverack M, Renshaw RW, Dubovi E, Tomlinson JE, Van de Walle GR, Divers TJ. First report of equine parvovirus-hepatitis-associated Theiler's disease in Europe. Equine Vet J 2020 Nov;52(6):841-847.
              doi: 10.1111/evj.13254pubmed: 32145096google scholar: lookup
            26. Ploss A, Kapoor A. Animal Models of Hepatitis C Virus Infection. Cold Spring Harb Perspect Med 2020 May 1;10(5).
              doi: 10.1101/cshperspect.a036970pubmed: 31843875google scholar: lookup
            27. Pronost S, Fortier C, Marcillaud-Pitel C, Tapprest J, Foursin M, Saunier B, Pitel PH, Paillot R, Hue ES. Further Evidence for in Utero Transmission of Equine Hepacivirus to Foals. Viruses 2019 Dec 5;11(12).
              doi: 10.3390/v11121124pubmed: 31817371google scholar: lookup
            28. Badenhorst M, de Heus P, Auer A, Rümenapf T, Tegtmeyer B, Kolodziejek J, Nowotny N, Steinmann E, Cavalleri JV. No Evidence of Mosquito Involvement in the Transmission of Equine Hepacivirus (Flaviviridae) in an Epidemiological Survey of Austrian Horses. Viruses 2019 Nov 1;11(11).
              doi: 10.3390/v11111014pubmed: 31683893google scholar: lookup
            29. Lattimer J, Stewart H, Locker N, Tuplin A, Stonehouse NJ, Harris M. Structure-function analysis of the equine hepacivirus 5' untranslated region highlights the conservation of translational mechanisms across the hepaciviruses. J Gen Virol 2019 Nov;100(11):1501-1514.
              doi: 10.1099/jgv.0.001316pubmed: 31490115google scholar: lookup
            30. Tegtmeyer B, Echelmeyer J, Pfankuche VM, Puff C, Todt D, Fischer N, Durham A, Feige K, Baumgärtner W, Steinmann E, Cavalleri JV. Chronic equine hepacivirus infection in an adult gelding with severe hepatopathy. Vet Med Sci 2019 Aug;5(3):372-378.
              doi: 10.1002/vms3.181pubmed: 31267690google scholar: lookup
            31. Tomlinson JE, Kapoor A, Kumar A, Tennant BC, Laverack MA, Beard L, Delph K, Davis E, Schott Ii H, Lascola K, Holbrook TC, Johnson P, Taylor SD, McKenzie E, Carter-Arnold J, Setlakwe E, Fultz L, Brakenhoff J, Ruby R, Trivedi S, Van de Walle GR, Renshaw RW, Dubovi EJ, Divers TJ. Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014-2018). J Vet Intern Med 2019 Jan;33(1):251-257.
              doi: 10.1111/jvim.15368pubmed: 30520162google scholar: lookup
            32. Tomlinson JE, Tennant BC, Struzyna A, Mrad D, Browne N, Whelchel D, Johnson PJ, Jamieson C, Löhr CV, Bildfell R, McKenzie EC, Laverack M, Renshaw RW, Dubovi E, Kapoor A, Meirs RS, Belgrave R, Engiles J, Van de Walle GR, Divers TJ. Viral testing of 10 cases of Theiler's disease and 37 in-contact horses in the absence of equine biologic product administration: A prospective study (2014-2018). J Vet Intern Med 2019 Jan;33(1):258-265.
              doi: 10.1111/jvim.15362pubmed: 30520132google scholar: lookup
            33. Rasche A, Sander AL, Corman VM, Drexler JF. Evolutionary biology of human hepatitis viruses. J Hepatol 2019 Mar;70(3):501-520.
              doi: 10.1016/j.jhep.2018.11.010pubmed: 30472320google scholar: lookup
            34. Lu G, Sun L, Ou J, Xu H, Wu L, Li S. Identification and genetic characterization of a novel parvovirus associated with serum hepatitis in horses in China. Emerg Microbes Infect 2018 Oct 23;7(1):170.
              doi: 10.1038/s41426-018-0174-2pubmed: 30348940google scholar: lookup
            35. Ramsay JD, Evanoff R, Mealey RH. Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome. J Virol 2018 Sep 15;92(18).
              doi: 10.1128/JVI.00314-18pubmed: 29976666google scholar: lookup
            36. Van Nguyen D, Van Nguyen C, Bonsall D, Ngo TT, Carrique-Mas J, Pham AH, Bryant JE, Thwaites G, Baker S, Woolhouse M, Simmonds P. Detection and Characterization of Homologues of Human Hepatitis Viruses and Pegiviruses in Rodents and Bats in Vietnam. Viruses 2018 Feb 28;10(3).
              doi: 10.3390/v10030102pubmed: 29495551google scholar: lookup
            37. Boukadida C, Fritz M, Blumen B, Fogeron ML, Penin F, Martin A. NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities. PLoS Pathog 2018 Feb;14(2):e1006863.
              doi: 10.1371/journal.ppat.1006863pubmed: 29415072google scholar: lookup
            38. Divers TJ, Tennant BC, Kumar A, McDonough S, Cullen J, Bhuva N, Jain K, Chauhan LS, Scheel TKH, Lipkin WI, Laverack M, Trivedi S, Srinivasa S, Beard L, Rice CM, Burbelo PD, Renshaw RW, Dubovi E, Kapoor A. New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product. Emerg Infect Dis 2018 Feb;24(2):303-310.
              doi: 10.3201/eid2402.171031pubmed: 29350162google scholar: lookup
            39. Tanaka T, Otoguro T, Yamashita A, Kasai H, Fukuhara T, Matsuura Y, Moriishi K. Roles of the 5' Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication. J Virol 2018 Apr 1;92(7).
              doi: 10.1128/JVI.01997-17pubmed: 29343570google scholar: lookup
            40. Lu G, Huang J, Yang Q, Xu H, Wu P, Fu C, Li S. Identification and genetic characterization of hepacivirus and pegivirus in commercial equine serum products in China. PLoS One 2017;12(12):e0189208.
              doi: 10.1371/journal.pone.0189208pubmed: 29216266google scholar: lookup
            41. Mao S, Wang M, Ou X, Sun D, Cheng A, Zhu D, Chen S, Jia R, Liu M, Sun K, Yang Q, Wu Y, Zhao X, Chen X. Virologic and Immunologic Characteristics in Mature Ducks with Acute Duck Hepatitis A Virus 1 Infection. Front Immunol 2017;8:1574.
              doi: 10.3389/fimmu.2017.01574pubmed: 29201029google scholar: lookup
            42. Ou X, Mao S, Cao J, Ma Y, Ma G, Cheng A, Wang M, Zhu D, Chen S, Jia R, Liu M, Sun K, Yang Q, Wu Y, Chen X. The neglected avian hepatotropic virus induces acute and chronic hepatitis in ducks: an alternative model for hepatology. Oncotarget 2017 Oct 10;8(47):81838-81851.
              doi: 10.18632/oncotarget.19003pubmed: 29137226google scholar: lookup
            43. Pfaender S, Walter S, Grabski E, Todt D, Bruening J, Romero-Brey I, Gather T, Brown RJ, Hahn K, Puff C, Pfankuche VM, Hansmann F, Postel A, Becher P, Thiel V, Kalinke U, Wagner B, Bartenschlager R, Baumgärtner W, Feige K, Pietschmann T, Cavalleri JM, Steinmann E. Immune protection against reinfection with nonprimate hepacivirus. Proc Natl Acad Sci U S A 2017 Mar 21;114(12):E2430-E2439.
              doi: 10.1073/pnas.1619380114pubmed: 28275093google scholar: lookup
            44. Walter S, Rasche A, Moreira-Soto A, Pfaender S, Bletsa M, Corman VM, Aguilar-Setien A, García-Lacy F, Hans A, Todt D, Schuler G, Shnaiderman-Torban A, Steinman A, Roncoroni C, Veneziano V, Rusenova N, Sandev N, Rusenov A, Zapryanova D, García-Bocanegra I, Jores J, Carluccio A, Veronesi MC, Cavalleri JMV, Drosten C, Lemey P, Steinmann E, Drexler JF. Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys. J Virol 2017 Jan 1;91(1).
              doi: 10.1128/JVI.01711-16pubmed: 27795428google scholar: lookup
            45. Hartlage AS, Cullen JM, Kapoor A. The Strange, Expanding World of Animal Hepaciviruses. Annu Rev Virol 2016 Sep 29;3(1):53-75.
            46. Smith DB, Becher P, Bukh J, Gould EA, Meyers G, Monath T, Muerhoff AS, Pletnev A, Rico-Hesse R, Stapleton JT, Simmonds P. Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family. J Gen Virol 2016 Nov;97(11):2894-2907.
              doi: 10.1099/jgv.0.000612pubmed: 27692039google scholar: lookup
            47. Gather T, Walter S, Pfaender S, Todt D, Feige K, Steinmann E, Cavalleri JM. Acute and chronic infections with nonprimate hepacivirus in young horses. Vet Res 2016 Sep 22;47(1):97.
              doi: 10.1186/s13567-016-0381-6pubmed: 27659317google scholar: lookup
            48. Zhu S, Li T, Liu B, Xu Y, Sun Y, Wang Y, Wang Y, Shuai L, Chen Z, Allain JP, Li C. Infection of Common Marmosets with GB Virus B Chimeric Virus Encoding the Major Nonstructural Proteins NS2 to NS4A of Hepatitis C Virus. J Virol 2016 Sep 15;90(18):8198-211.
              doi: 10.1128/JVI.02653-15pubmed: 27384651google scholar: lookup
            49. Lu G, Sun L, Xu T, He D, Wang Z, Ou S, Jia K, Yuan L, Li S. First Description of Hepacivirus and Pegivirus Infection in Domestic Horses in China: A Study in Guangdong Province, Heilongjiang Province and Hong Kong District. PLoS One 2016;11(5):e0155662.
              doi: 10.1371/journal.pone.0155662pubmed: 27182887google scholar: lookup
            50. Berg MG, Lee D, Coller K, Frankel M, Aronsohn A, Cheng K, Forberg K, Marcinkus M, Naccache SN, Dawson G, Brennan C, Jensen DM, Hackett J Jr, Chiu CY. Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection. PLoS Pathog 2015 Dec;11(12):e1005325.
              doi: 10.1371/journal.ppat.1005325pubmed: 26658760google scholar: lookup
            51. Pfaender S, Walter S, Todt D, Behrendt P, Doerrbecker J, Wölk B, Engelmann M, Gravemann U, Seltsam A, Steinmann J, Burbelo PD, Klawonn F, Feige K, Pietschmann T, Cavalleri JV, Steinmann E. Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure. J Gen Virol 2015 Sep;96(9):2636-2642.
              doi: 10.1099/vir.0.000208pubmed: 26041875google scholar: lookup
            52. Corman VM, Grundhoff A, Baechlein C, Fischer N, Gmyl A, Wollny R, Dei D, Ritz D, Binger T, Adankwah E, Marfo KS, Annison L, Annan A, Adu-Sarkodie Y, Oppong S, Becher P, Drosten C, Drexler JF. Highly divergent hepaciviruses from African cattle. J Virol 2015 Jun;89(11):5876-82.
              doi: 10.1128/JVI.00393-15pubmed: 25787289google scholar: lookup